Lupin has inked an agreement with Valorum for biosimilar Armlupeg, and it has received a tentative OK from the FDA for generic Mayzent.
Rochester paid $3.36 million for the old Care Pharmacy site and invited developers for a tour. Will Golick's stay? Here are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback